Product Details
Application
- Immunization
- Cell based assay (FACS or functional assay)
- Screening (ELISA)
Synonyms
D2DR, D2R
Source
Human DRD2 Full Length Protein (VLP) (DR2-H52P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Cys 443 (Accession # P14416-1).
Predicted N-terminus: Asp
Molecular Characterization
*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.
Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.
Synthesis Process
Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Formulation
The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).
Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA

Immobilized Human DRD2 Full Length Protein (VLP) (Cat. No. DR2-H52P3) at 5 μg/mL (100 μL/well) can bind Anti-DRD2 Antibody, Mouse IgG2a with a linear range of 1-63 ng/mL (QC tested).
Protocol
Customer Reviews Writing Reviews




















